The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats.
Rubidium and lithium are alkali metals belonging to the same periodic series as sodium, potassium and cesium. In the present report the effects of lithium and rubidium on animal reactivity to stressful stimuli and on dopamine output in the nucleus accumbens were studied. A dose-response curve with rubidium, administered acutely before exposure to unavoidable stress, showed a maximal protective activity on escape deficit development at the dose of 0. 41 mEq/kg. Rubidium injected at doses of 0.008-0.08 mEq/kg 72 h before the unavoidable stress had the same efficacy as the acute 0. 41 mEq/kg dose. Tolerance to the effect of rubidium developed after 9 days of treatment and, on day 15, rats presented a spontaneous escape deficit. The acute effect of lithium, administered for 3.5 days at the dose of 0.8 mEq/kg, i.p. twice a day before the exposure to unavoidable stress, was analogous to that of rubidium, but after repeated treatment a spontaneous escape deficit developed. Rats showing an escape deficit secondary to chronic stress also presented decreased extraneuronal dopamine concentrations in the nucleus accumbens. Accordingly, microdialysis studies showed significantly lower extracellular dopamine levels in rats chronically treated with lithium or rubidium compared to control animals. Cocaine (5 mg/kg i. p.) administered acutely increased extracellular dopamine concentrations in control rats, as well as in rats chronically stressed or chronically treated with lithium or rubidium. However, the dopamine increase was significantly higher in controls compared to the other groups. In conclusion, long-term treatment with lithium or rubidium, or the exposure to chronic stress, produced a condition of behavioral hypo-reactivity accompanied by a decreased dopamine output in the nucleus accumbens.
Gambarana
C
C
Pharmacology Unit, Institute of 'Clinica delle Malattie Nervose e Mentali', University of Siena, Siena, Italy. gambarana@unisi.it
Ghiglieri
O
O
Masi
F
F
Scheggi
S
S
Tagliamonte
A
A
De Montis
M G
MG
D000818:Animals; D018692:Antimanic Agents / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D002712:Chlorides / Q000494:pharmacology*; D002908:Chronic Disease; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D004924:Escape Reaction / Q000187:drug effects; D018021:Lithium Chloride / Q000494:pharmacology*; D008297:Male; D017551:Microdialysis; D009474:Neurons / Q000378:metabolism; D009714:Nucleus Accumbens / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012413:Rubidium / Q000494:pharmacology*; D013312:Stress, Physiological / Q000188:drug therapy* / Q000378:metabolism
D018692:Antimanic Agents; D002712:Chlorides; D018765:Dopamine Uptake Inhibitors; D018021:Lithium Chloride; D003042:Cocaine; D012413:Rubidium; C032710:rubidium chloride; D004298:Dopamine